Atrial Functional Mitral Regurgitation and Tricuspid Regurgitation
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorBarts & The London NHS Trust
About this trial
A prospective, observational cohort study designed to identify clinical phenotypes and evaluate predictors \& outcomes of functional mitral and tricuspid valve regurgitation in patients with atrial fibrillation.
Participant will under go:
* Baseline echocardiography * Cpex Echocardiography * Blood test: BNP * 1 year follow up Echocardiography
Participants will be stratified into three subgroups:
* Atrial Functional MR * Atrial Functional TR * Mixed MR \& TR
Eligibility criteria
Qualifiers
Informed consent
Age of 18 years or older
Atrial fibrillation
Moderate or severe atrial valve disease
Disqualifiers
Unwilling or unable to give consent
Left ventricular impairment (ejection fraction < 50%).
Primary/organic valve disease
Trial design
Treatments tested in this trial
- Echocardiogram
Treatment groups
No treatment groups listed
Locations
1St Bartholomew's Hospital London United Kingdom
Sponsors and collaborators
Barts & The London NHS Trust
Lead sponsor
Source ClinicalTrials.gov